top of page

Innovating Psoriatic Arthritis Care with iPROLEPSIS

29 Οκτ 2024

Insights Shared in Psoriasis Magazine: An Interview with Psoriasis Patienten Nederland

We are pleased to share that we were interviewed by Psoriasis Patients Netherlands (https://psoriasispatientennederland.nl/) and featured in their Psoriasis Magazine. This dedicated volunteer organisation advocates for over 300,000 people in the Netherlands affected by psoriasis and psoriatic arthritis.


Supporting Patients

Psoriasis Patients Netherlands provides clear, unbiased information on managing chronic conditions and serves as a vital link between patients, healthcare providers, and the latest research. Their focus is on patient support, offering resources like their magazine, social media, and direct support channels, creating an invaluable network for those navigating these challenging conditions.


Digital Health Innovation

The Erasmus MC in Rotterdam, through the iPROLEPSIS Consortium, is developing an app to help patients with psoriatic arthritis monitor their condition using digital health tools. Over 600 patients across four countries will use the app and smartwatches to track their heart rate, activity, and symptoms daily, along with periodic video analyses and healthcare visits.


Key Research Areas

The key research areas include exploring the roles of genetics, gut microbiome, and lifestyle factors. Collaborations with organizations like HPOS will soon allow individuals with psoriasis to contribute their data, supporting predictive models for earlier diagnosis.


Empowering Patients Through Partnership

The Erasmus MC’s iPROLEPSIS study is not just about technological development; it is driven by the stories of patient partners like Elaine and Wendy. Their lived experience with psoriatic arthritis informs our work, ensuring that the tools we develop support their needs and enhance their well-being. With patient partners at the core of the iPROLEPSIS initiative, we are creating a future where digital tools empower psoriatic arthritis patients.

Εγγραφείτε στο ενημερωτικό μας δελτίο

Ευχαριστούμε για την υποβολή!

Λογότυπο iPROLEPSIS

Το έργο iPROLEPSIS λαμβάνει χρηματοδότηση από την Ευρωπαϊκή Ένωση βάσει της Συμφωνίας Επιχορήγησης με Αρ.101095697.

EN-Funded by the EU-PANTONE.png

Χρηματοδοτείται από την Ευρωπαϊκή Ένωση. Ωστόσο, οι απόψεις και οι απόψεις που εκφράζονται είναι αυτές του συγγραφέα ή των συγγραφέων και δεν αντικατοπτρίζουν απαραίτητα εκείνες της Ευρωπαϊκής Ένωσης ή του Ευρωπαϊκού Οργανισμού Υγείας και Ψηφιακής Εκτελεστικής Υπηρεσίας. Ούτε η Ευρωπαϊκή Ένωση ούτε ο Ευρωπαϊκός Εκτελεστικός Οργανισμός Υγείας και Ψηφιακής Υπηρεσίας μπορούν να θεωρηθούν υπεύθυνοι για αυτά.

© 2025 by iPROLEPSIS Consortium

bottom of page